A Branford life sciences company has earned national recognition for a new technology that helps doctors predict the way cancer patients will respond to immunotherapy drugs.

IsoPlexis Corp.’s IsoCode Chip earned the leading spot in The Scientist magazine’s Top 10 Innovations of 2017, a list that identifies the nation’s most groundbreaking life science technologies.